Norges Bank
INBX

Norges Bank’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Norges Bank’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,000
Closed -$180K – 2220
2020
Q3 		$180K Buy
+10,000
New +$181K ﹤0.01% 2121

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Norges Bank's INBX Position: Q4 2020 in Review

Norges Bank sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2020, closing a stake of 10,000 shares — an estimated $180K sold.

Norges Bank first reported a position in INBX in Q3 2020 and held it in 1 quarter. The position peaked at $180K in Q3 2020. 51 funds tracked by Wall St. Rank hold INBX as of Q4 2020.

  • Norges Bank reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Norges Bank sold 10,000 Inhibrx, Inc. Common Stock shares in Q4 2020, an estimated $180K.
  • Norges Bank first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Norges Bank's Inhibrx, Inc. Common Stock position peaked at $180K in Q3 2020.
  • 51 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2020.

Based on Norges Bank's 13F filing for Q4 2020, filed 10 Feb 2021.